Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4159441 | Journal of Pediatric Surgery | 2008 | 4 Pages |
Abstract
An association between oxcarbazepine therapy and hepatic adenoma (HA) has been documented in animal models but not observed in humans. The authors report a case of a 16-year-old girl on oxcarbazepine therapy for seizure disorder who presented with a giant HA. Pathology of the HA was notable for marked periductal fibrosis and glycoprotein inclusions in the nontumor liver. The patient was not on oral contraceptives and has no other known risk factors for HA.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
T.B. Lautz, M.J. Finegold, A.C. Chin, R.A. Superina,